-
公开(公告)号:EP2566482A1
公开(公告)日:2013-03-13
申请号:EP11718104.0
申请日:2011-05-09
申请人: Institut National de la Santé et de la Recherche Médicale , Université Paris-Sud 11 , Centre National de la Recherche Scientifique (CNRS)
发明人: RAFESTIN-OBLIN, Marie-Edith , ALAMI, Mouad , LOOSFELT, Hugues , HAMZE, Abdallah , KHAN, Ali Junaid , TIKAD, Abdellatif , LOMBES, Marc , BRION, Jean-Daniel
IPC分类号: A61K31/56 , A61K31/567 , A61K31/568 , A61K31/5685 , A61K31/569 , A61K31/57 , A61K31/575 , C07J1/00 , C07J9/00 , C07J11/00 , C07J63/00 , A61P15/04 , A61P15/18 , A61P35/00
CPC分类号: C07J63/008 , A61K31/56 , A61K31/567 , A61K31/568 , A61K31/5685 , A61K31/569 , A61K31/57 , A61K31/575 , C07J1/0011 , C07J1/0022 , C07J1/0025 , C07J3/00 , C07J7/0005 , C07J7/002 , C07J7/007 , C07J9/00 , C07J11/00 , C07J21/006
摘要: The present invention relates to a compound of formula (I): for its use as progesterone receptor antagonist, in particular for its use for the prevention and/or the treatment of cancer or uterine pathologies.